Drugs.com - FDA MedWatch Alerts

Alvogen Issues Voluntary Nationwide Recall for One Lot of Fentanyl Transdermal System 25 mcg/h Due to a Defective Delivery System

Audience: Consumer, Health Professional, Pharmacy January 31, 2025 – Morristown, NJ -- Alvogen, Inc. is voluntarily recalling one lot of Fentanyl Transdermal System 25 mcg/h transdermal patches to the consumer level. The reason for the recall...

Apr 26, 2025 - 14:23
 0
Alvogen Issues Voluntary Nationwide Recall for One Lot of Fentanyl Transdermal System 25 mcg/h Due to a Defective Delivery System
Audience: Consumer, Health Professional, Pharmacy January 31, 2025 – Morristown, NJ -- Alvogen, Inc. is voluntarily recalling one lot of Fentanyl Transdermal System 25 mcg/h transdermal patches to the consumer level. The reason for the recall...
Read More

Tags:

Previous Article

ICU Medical Issues Nationwide Recall of Potassium Chloride Injection, 20 mEq and...

Next Article

Provepharm Inc. Issues Recall of One Lot of Phenylephrine Hydrochloride Injectio...

Related Posts

Gilead Issues Voluntary Nationwide Recall of One Lot of Veklury (Remdesivir) for Injection 100 mg/vial Due to the Presence of a Glass Particle

Gilead Issues Voluntary Nationwide Recall of One Lot of...

Apr 26, 2025  0

Endo Expands Voluntary Recall of Clonazepam Orally Disintegrating Tablets, USP (C-IV) Due to Potential Product Carton Strength Mislabeling

Endo Expands Voluntary Recall of Clonazepam Orally Disi...

Apr 26, 2025  0

Shoppers-Plaza Issues Voluntary Nationwide Recall of Fouzee Sugarlin Herbal Formula Due To Presence Of Undeclared Metformin And Glyburide

Shoppers-Plaza Issues Voluntary Nationwide Recall of Fo...

Apr 26, 2025  0